Latest Articles
AI imaging technique detects early endometrial cancer with high accuracy - News-Medical
AI imaging technique detects early endometrial cancer with high accuracy News-Medical
Published: June 19, 2026, 2:55 a.m.
The role of omentin-1 in female reproduction: a critical review.
White adipose tissue is now recognized as an active endocrine organ that secretes numerous bioactive molecules known as adipokines. These proteins regulate essential physiological processes, including energy metabolism, inflammation, and …
Published: June 19, 2026, midnight
Research progress of ferroptosis in gynecological diseases.
The concept of ferroptosis debuted as a newly defined programmed cell death in 2012. Among programmed cell death mechanisms, ferroptosis stands out as being fundamentally dependent on iron. At the …
Published: June 19, 2026, midnight
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise - Newswise
Quick Optical Biopsy Could Be Early Detection Method for Endometrial Cancer | Newswise Newswise
Published: June 18, 2026, 11:20 p.m.
Quick optical biopsy could be early detection method for endometrial cancer | Newswise - Newswise
Quick optical biopsy could be early detection method for endometrial cancer | Newswise Newswise
Published: June 18, 2026, 8:15 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter
Published: June 18, 2026, 2:24 p.m.
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia - Vera Health
Cholesterol Accumulation Impairs Progestin Response in Fertility-Preserving Treatment of Endometrial Cancer and Atypical Hyperplasia Vera Health
Published: June 18, 2026, 12:22 p.m.
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer OncLive
Published: June 17, 2026, 9:31 p.m.
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer - OncLive
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer OncLive
Published: June 17, 2026, 9:11 p.m.
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer - HMP Global Learning Network
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer HMP Global Learning Network
Published: June 17, 2026, 8:26 p.m.
Link copied to clipboard!